Reed Thomas D.

Avg. Two Year Performance

63% Avg. Purchase Return
28% Compound
(9%) Avg. Sale Return
(4%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return60%44%36%169%63%
Purchase Success Rate1 of 11 of 11 of 11 of 11 of 1
Average Sale Return(26%)(5%)(30%)12%(9%)
Sale Success Rate2 of 53 of 53 of 54 of 50 of 5
Drugs » Biotechnology

Chief Science Officer:

Holdings: 255.87K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--